Back HCV Prevention

HCV Sexual Transmission: HIV Negative May Be at Risk, More Awareness and Testing Needed

Hepatitis C virus (HCV) is known to be sexually transmitted among HIV positive men who have sex with men, but HIV negative men may be at risk as well, according to recent reports. Other recent studies have looked at awareness of HCV sexual transmission and screening practices, suggesting that improvement is needed in both areas.

alt

Read more:

July 28 Is World Hepatitis Day [VIDEO]

July 28 is World Hepatitis Day, an opportunity to raise awareness about viral hepatitis and its consequences. This year's theme -- "Think Again" -- emphasizes that while hepatitis B and C are major causes of death worldwide, viral hepatitis remains remarkably neglected. The World Health Organization (WHO) and others held a press briefing at the 20th International AIDS Conference last week in Melbourne to raise awareness.

alt

Read more:

EASL 2014: Researchers Look at Treatment as Prevention for Hepatitis C

Widespread hepatitis C treatment with effective new direct-acting antivirals could dramatically reduce hepatitis C virus (HCV) transmission, but making this work on a large scale will require efforts to scale up HCV screening and bring down drug costs, according to several presentations at the EASL International Liver Congress this month in London.

alt

Read more:

Studies Shed Light on Hepatitis C Virus Sexual Transmission among Gay Men

Hepatitis C virus (HCV) transmission among HIV positive gay men has leveled off in Amsterdam -- one of the first cities with an outbreak of apparently sexually transmitted HCV infection -- and it continues to be rare among HIV negative men who have sex with men, according to recent studies. Other research looked at HCV sexual transmission among HIV positive and negative men in Switzerland, and at the association between HCV viral load in blood and semen.

alt

Read more:

EASL 2014: Treatment as Prevention for Drug Users Could Slash HCV Prevalence

A combination of increased testing, improved linkage to care, and earlier treatment with interferon-free regimens has the potential to substantially reduce the incidence and prevalence of hepatitis C among people who inject drugs in France over the next 10 years, as well as reducing the burden of disease arising from cirrhosis over 40 years, according to a study presented at the 49th EASL International Liver Congress (EASL 2014) last week in London.

alt

Read more: